SEC 13F Intelligence

Rtw Investments, LP / TXG

Rtw Investments, LP’s 10x Genomics Inc Position

Does Rtw Investments, LP own 10x Genomics Inc (TXG)? Not currently — the last reported position was 502.9K shares worth $11M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q3 2024
Shares
502.9K
% of Portfolio
+0.16%
Quarters Held
21
position exited

Position History TXG

Reported value by quarter
Q3 ’19: $252,000Q3 ’19Q4 ’19: $381,000Q1 ’20: $12MQ2 ’20: $57MQ2 ’20Q3 ’20: $82MQ4 ’20: $94MQ1 ’21: $129MQ1 ’21Q2 ’21: $144MQ3 ’21: $107MQ4 ’21: $109MQ4 ’21Q1 ’22: $56MQ2 ’22: $43MQ3 ’22: $18MQ3 ’22Q4 ’22: $32MQ1 ’23: $52MQ2 ’23: $82MQ2 ’23Q3 ’23: $63MQ4 ’23: $87MQ1 ’24: $58MQ1 ’24Q2 ’24: $10MQ3 ’24: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024502.9K$11M+0.16%
Q2 2024502.9K$10M+0.15%
Q1 20241.55M$58M+0.86%
Q4 20231.55M$87M+1.35%
Q3 20231.52M$63M+1.32%
Q2 20231.46M$82M+1.56%
Q1 2023929.3K$52M+1.08%
Q4 2022872.6K$32M+0.65%
Q3 2022639.7K$18M+0.42%
Q2 2022959.5K$43M+1.12%
Q1 2022734.5K$56M+1.16%
Q4 2021734.5K$109M+1.60%
Q3 2021734.5K$107M+1.61%
Q2 2021734.5K$144M+2.17%
Q1 2021711.5K$129M+2.01%
Q4 2020660.9K$94M+1.57%
Q3 2020660.9K$82M+1.98%
Q2 2020636.1K$57M+1.60%
Q1 2020190.1K$12M+0.51%
Q4 20195.0K$381,000+0.01%
Q3 20195.0K$252,000+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rtw Investments, LP’s full portfolio or all institutional holders of TXG.